ISEE IVERIC bio Inc

Price (delayed)

$10.455

Market cap

$1.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.12

Enterprise value

$1.03B

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing ...

Highlights
IVERIC bio's quick ratio has soared by 102% YoY and by 33% from the previous quarter
The debt has declined by 15% since the previous quarter
The equity has soared by 99% YoY but it has decreased by 8% from the previous quarter
IVERIC bio's net income has decreased by 27% YoY and by 7% from the previous quarter

Key stats

What are the main financial stats of ISEE
Market
Shares outstanding
116.42M
Market cap
$1.22B
Enterprise value
$1.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$122.26M
EBITDA
-$122.22M
Free cash flow
-$107.09M
Per share
EPS
-$1.12
Free cash flow per share
-$0.9
Book value per share
$2.88
Revenue per share
$0
TBVPS
$2.97
Balance sheet
Total assets
$352.71M
Total liabilities
$19.55M
Debt
$1.34M
Equity
$333.15M
Working capital
$331.8M
Liquidity
Debt to equity
0
Current ratio
18.31
Quick ratio
18.04
Net debt/EBITDA
1.56
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-42.3%
Return on equity
-46.1%
Return on invested capital
-126.7%
Return on capital employed
-36.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ISEE stock price

How has the IVERIC bio stock price performed over time
Intraday
4.86%
1 week
11.22%
1 month
-0.43%
1 year
72.52%
YTD
-37.47%
QTD
-37.88%

Financial performance

How have IVERIC bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$122.56M
Net income
-$122.26M
Gross margin
N/A
Net margin
N/A
IVERIC bio's net income has decreased by 27% YoY and by 7% from the previous quarter
The operating income is down by 27% YoY and by 7% from the previous quarter

Growth

What is IVERIC bio's growth rate over time

Valuation

What is IVERIC bio stock price valuation
P/E
N/A
P/B
3.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ISEE's EPS is up by 2.6% year-on-year
The equity has soared by 99% YoY but it has decreased by 8% from the previous quarter
The stock's price to book (P/B) is 39% less than its last 4 quarters average of 5.7 and 6% less than its 5-year quarterly average of 3.7

Efficiency

How efficient is IVERIC bio business performance
The ROIC has declined by 14% year-on-year and by 5% since the previous quarter
ISEE's return on equity is up by 10% since the previous quarter and by 2.9% year-on-year
ISEE's return on assets is up by 9% since the previous quarter and by 2.3% year-on-year

Dividends

What is ISEE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ISEE.

Financial health

How did IVERIC bio financials performed over time
IVERIC bio's quick ratio has soared by 102% YoY and by 33% from the previous quarter
ISEE's current ratio has surged by 97% year-on-year and by 33% since the previous quarter
The debt is 100% smaller than the equity
The equity has soared by 99% YoY but it has decreased by 8% from the previous quarter
The debt has declined by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.